In Florida, Anuvia Plant Nutrients today announced it has raised $103 million in Series C funding, co-led by TPG ART and Pontifax Global Food and Agriculture Technology Fund (Pontifax AgTech), with additional investment from Generate and Piva Capital.
Those slow-release fertilizers: the backstory.
Granulated fertilizers have been around for quite a number of years. Most of them aim to stabilize the rate of nitrogen release. Scotts, Georgia-Pacific, Agrium and Growth Products are some of the companies that market a range of them. Overall, there’s a 10%+ yield bump, reduced risk of fertilizer burn and less labor cost in re-application. So, they’re popular. But not very sustainable, and companies are looking for sustainable options.
Share:
AgTech Start-up Delivers up to 32% Reduction of Greenhouse Gases, Helping Ag and Food Industry to Reach Scope 3 Sustainability Targets
Anuvia™ Plant Nutrients today announced it has raised $103 million in Series C funding, co-led by TPG ART and Pontifax Global Food and Agriculture Technology Fund (Pontifax AgTech), with additional investment from Generate and Piva Capital.
Anuvia will use the financing to increase the production capacity and expand commercialization of its innovative nutrient delivery technology, as commercial agriculture continues its transformation into more sustainable and profitable practices. Anuvia s SymTRX™ is already in commercial use on U.S. farms, with use expected to increase to reach 20 million acres by 2025.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Pairwise Raises $90 Million to Bring New Varieties of Fruits and Vegetables to Market
February 3, 2021 GMT
DURHAM, N.C. (BUSINESS WIRE) Feb 3, 2021
Pairwise announced the closing of its $90 million Series B funding round, signaling a new frontier in healthy, sustainable food innovation. Funding for the round was led by Pontifax Global Food and Agriculture Technology Fund (Pontifax AgTech), a pioneering growth capital investor in food and agriculture technology, and existing investor Deerfield Management Company (Deerfield), an investment firm dedicated to advancing healthcare through investment, information and philanthropy. Also joining the Series B round are new investor Temasek, an investment company headquartered in Singapore, and existing investor Leaps by Bayer, which invests in paradigm-shifting advances in the life sciences sector, including agriculture and health.